Bemnifosbuvir hemisulfate (AT-527), a hemisulfate salt of AT-511, a guanosine nucleotide proagent, is a potent and orally active HCV viral replication inhibitor. Bemnifosbuvir hemisulfate is highly effective in the control of SARS-CoV-2 (COVID-19) infection in vitro (EC90=0.47 µM). Bemnifosbuvir hemisulfate has pangenotypic antiviral activity[1][2][3].
Molecular Weight:
630.58
Purity:
99.38
CAS Number:
[2241337-84-6]
Formula:
C24H33FN7O7P.1/2H2O4S
Target:
HCV,SARS-CoV
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted
